Related by context. All words. (Click for frequent words.) 67 TG# [003] 67 CTAP# Capsules 67 VA# [002] 67 Symadex 66 INT# [002] 66 ENMD # 66 nucleotide analog 66 IMA# 66 HQK 66 ESBA# 66 oral prodrug 66 metaglidasen 65 Vilazodone 65 AEG# 65 Sym# 65 cannabinor 65 PRT# 65 ALGRX 65 Xanafide 65 Intravail ® 65 phase IIa clinical 65 THR beta agonist 65 Azedra 65 proteasome inhibitor 64 lomitapide 64 teriflunomide 64 vidofludimus 64 selective kinase inhibitor 64 Lixivaptan 64 JAK2 inhibitor 64 CCX# 64 Tyrima 64 Elagolix 64 JAK inhibitors 64 Archexin 64 ProSavin 64 preclinically 64 orally administered inhibitor 64 Traficet EN 64 PRTX 64 favorable pharmacokinetic profile 64 CBLC# 64 HuLuc# 64 CYT# potent vascular disrupting 64 LHRH antagonists 64 R#/MEM # 64 Mipomersen 63 OHR/AVR# 63 tezampanel 63 ulimorelin 63 indibulin 63 ISIS # 63 receptor tyrosine kinase inhibitor 63 CCR9 antagonist 63 RSD# oral 63 Ophena TM 63 Bicifadine 63 MTP inhibitor 63 Phase IIa trials 63 Nanobody ® 63 Tasimelteon 63 Omacetaxine 63 Tesetaxel 63 TriRima 63 TRV# [001] 63 CRLX# 63 Onconase 63 HCV protease inhibitor 63 selective modulator 63 GAMMAGARD 63 Myocet 63 Squalamine 63 ATL/TV# 63 liposomal formulation 63 Zoraxel 63 radiation sensitizer 63 forodesine 63 diabetic neuropathic pain 63 angiogenesis inhibitor 63 romazarit 63 RGB # 63 elotuzumab 63 NNR Therapeutics 63 Guanilib 63 MAGE A3 ASCI 63 TPI ASM8 63 RLY# 63 INCB# [001] 63 LY# [003] 63 SERMs 63 PHX# 63 XmAb# 63 GLYX 63 phase IIb trial 63 corticosteroid dexamethasone 63 direct thrombin inhibitors 62 XmAb 62 PNP inhibitor 62 CytoFabTM 62 DDP# 62 ganetespib 62 AEGR 62 Intravenous CP 62 oral salmon calcitonin 62 alvespimycin 62 Valdoxan 62 PDE4 inhibitor 62 pan HDAC inhibitor 62 oral renin inhibitor 62 OMP #M# 62 tiapamil 62 leading oral taxane 62 PSMA ADC 62 Carfilzomib 62 MKC# MKC# PP 62 MEK inhibitors 62 MGd 62 Synavive 62 PSN# [002] 62 selective agonist 62 HGS# 62 Arikace 62 Factor VIIa 62 obatoclax 62 sodium glucose cotransporter 62 Abbokinase 62 nalbuphine ER 62 renin inhibitor 62 ApoB SNALP 62 EyeGate 62 Phase Ib study 62 zileuton 62 S/GSK# 62 IRX 2 62 systemically administered 62 IPL# 62 vascular disrupting agents 62 protein kinase inhibitor 62 deforolimus 62 orally bioavailable 62 Pimavanserin 62 generation FBPase inhibitor 62 ATL# [001] 62 CCR5 antagonist 62 preclinical efficacy 62 Nanobody 62 ELACYT 62 Blinatumomab 62 ponatinib 62 Anticalins R 62 OncoVEX 62 antithrombotic 62 trodusquemine 62 JAK2 inhibitors 62 anticancer compound 62 Spiegelmer ® 62 Kamada AAT 62 Personalized Immunotherapy 62 nanopharmaceutical 62 R roscovitine 62 pharmacodynamic profile 62 glucokinase activator 62 mGluR2 NAM 62 radezolid 62 pomalidomide 62 NVA# 61 Technosphere Insulin 61 Trofex 61 PI3K/Akt pathway inhibitor 61 vascular disrupting agent 61 selective androgen receptor modulator 61 therapeutic monoclonal antibody 61 gefitinib Iressa 61 MEK inhibitor 61 Phase 1b trial 61 nucleoside analog 61 TBC# 61 dexpramipexole 61 GKAs 61 mertansine 61 relapsed MM 61 Zybrestat 61 Safinamide 61 demonstrated antitumor activity 61 Plicera 61 Bezielle 61 riociguat 61 Elocalcitol 61 Tezampanel 61 Virulizin ® 61 dextofisopam 61 renin inhibitors 61 brivaracetam 61 TRO# 61 Deforolimus 61 NN# [001] 61 INCB# [003] 61 eniluracil 61 aleglitazar 61 PEG SN# 61 novel VDA molecule 61 HCV protease inhibitors 61 Silodosin 61 mTOR inhibitors 61 JAK inhibitor 61 CDK inhibitor 61 enzastaurin 61 anticancer agent 61 EOquin 61 targeted radiotherapeutic 61 trospium 61 CR# vcMMAE 61 DCCR 61 samalizumab 61 R#/MEM 61 LEUKINE 61 RNAi therapeutic targeting 61 OncoVEX GM CSF 61 INCB# [002] 61 DACH platinum 61 Aliskiren 61 tranilast 61 Azedra TM 61 prucalopride 61 Aflibercept 61 tanespimycin 61 phase IIb clinical 61 Solulin 61 ANG# 61 ruxolitinib 61 Vidofludimus 61 phase IIb study 61 JAK1 61 neuroprotective properties 61 PRX # 61 REG1 61 PRX# 61 ACAPODENE 61 ARIKACE ™ 61 pharmacokinetic PK study 61 torezolid 61 histone deacetylase HDAC inhibitor 61 thalidomide Thalomid 61 CTA# 61 CEQ# 61 fluvastatin 61 favorable tolerability 61 QuadraSphere 61 PDE# inhibitors 61 Aclidinium 61 solithromycin 61 Denufosol 60 hour bronchodilation 60 Panzem R NCD 60 OXi# 60 sapacitabine 60 drug eluting stent DES 60 Eltrombopag 60 MAP# 60 Triolex 60 SARMs 60 hyperphenylalaninemia HPA due 60 schizophrenia CIAS 60 delta isoform 60 DB# [003] 60 Janus Kinase 60 atacicept 60 SAR# [002] 60 ANCHOR trial 60 Anticalins 60 CYPHER R Sirolimus eluting 60 orally dosed 60 SRT# [003] 60 Quinamed 60 PSN# [001] 60 alagebrium 60 PEGylated interferon 60 anti amnesic 60 DXL# 60 generation purine nucleoside 60 teduglutide 60 Amplimexon 60 HuMax EGFr 60 Factor Xa inhibitor 60 Pazopanib 60 predictive biomarkers 60 inhibitor RG# 60 Anavex #-# 60 ToGA 60 novel peptide 60 Vicinium TM 60 NGX# 60 OvaRex ® MAb 60 Zingo TM 60 cMET 60 delta opioid receptor 60 basal bolus regimen 60 eTag assays 60 phase IIa 60 inhaled formulation 60 TACI Ig 60 dose cohort 60 CA4P 60 Pertuzumab 60 Soliris eculizumab 60 Solazed TM 60 Evoltra ® 60 PS# [001] 60 NATRECOR ® 60 TKM ApoB 60 rFIXFc 60 CLORETAZINE TM VNP#M 60 CORT # 60 Epanova 60 NP2 Enkephalin 60 proteasome inhibitors 60 Myolimus 60 Memryte 60 Hsp# inhibitors 60 tumor xenograft models 60 Vidaza azacitidine 60 Novolimus 60 Phase 1a clinical 60 fosbretabulin 60 rFVIIa 60 aclidinium 60 Cleviprex TM clevidipine 60 histone deacetylase HDAC 60 eprotirome 60 GV# [001] 60 AZX# 60 Vascugel 60 tecarfarin 60 immune modulating 60 rifalazil 60 oral picoplatin 60 Zoraxel TM 60 trial evaluating PRX# 60 pertuzumab 60 davunetide intranasal AL 60 DermaVir Patch 60 highly selective inhibitor 60 Intarcia 60 investigational pan BCR 60 ospemifene 60 Phase #b/#a clinical 60 INTEGRILIN 60 BNC# 60 Panzem R 60 ADP receptor antagonist 60 Phase 2b clinical trials 60 EXPAREL TM 60 5 HT3 antagonist 60 Cannabinor 60 Dalbavancin 60 intranasal formulation 60 BCR ABL inhibitors 60 deferiprone 60 Aurora kinase 60 Genz # 60 Dasatinib 60 Debio 60 atrasentan 60 BrachySil TM 60 Sapacitabine 60 ARX# [001] 60 Phase 2a Clinical Trial 60 rhIGF-I/rhIGFBP-3 60 NEVO ™ 60 Lisofylline 60 Phase Ib II 60 HMG CoA reductase inhibitors 60 non nucleoside inhibitor 60 epothilone 60 IMiDs ® 60 albiglutide 60 antiangiogenic therapy 60 BrachySil 60 Radezolid 60 CRD5 59 TH# [003] 59 MLN# 59 Oral NKTR 59 Chrysalin 59 AIR# [001] 59 PGL# 59 Aviptadil 59 multicenter Phase II 59 multi kinase inhibitor 59 Alocrest 59 Naproxcinod 59 HCD# [002] 59 Phase #b/#a trial 59 potency selectivity 59 FOLOTYN ® 59 efficacy endpoint 59 selective antagonist 59 Clonicel 59 #I TM# 59 Aplidin 59 BCX# 59 cobiprostone 59 DOS# 59 beta interferons 59 TMC# [002] 59 vemurafenib 59 BAY #-# 59 evaluating tivozanib 59 Apoptone 59 Phase 1b clinical trials 59 eltrombopag 59 Hsp# inhibition 59 OvaRex R 59 ALN TTR 59 ostarine 59 GFT# 59 PLK1 SNALP 59 novel oral anticoagulant 59 Microplasmin 59 Solazed 59 catheter occlusion 59 Civacir 59 Corlux 59 EDEMA3 59 investigational compounds 59 AMPK activators 59 Delafloxacin 59 Phase IIb clinical trials 59 Darusentan 59 CYC# 59 acyclovir Lauriad R 59 pharmacodynamic properties 59 oral ridaforolimus 59 elacytarabine 59 ONCONASE R 59 PXD# 59 MKC# 59 oral talactoferrin 59 investigational humanized monoclonal antibody 59 immunomodulator 59 EndoTAG 59 DU #b 59 peptidomimetic 59 MYDICAR 59 cediranib 59 PROMUS Element Stent 59 ADAGIO study 59 clevidipine 59 antiviral efficacy 59 GRN# 59 rxRNA 59 oral anticoagulant 59 crofelemer 59 TOLAMBA 59 Muraglitazar 59 5 HT2C receptor 59 seliciclib CYC# 59 VAPRISOL 59 Fenretinide 59 targeted antifolate 59 MYDICAR ® 59 Cand5 59 drug zotarolimus 59 castrate resistant prostate cancer 59 EndoTAG TM -1 59 LymphoStat B TM 59 Combo Stent 59 sumatriptan DosePro 59 Romidepsin 59 Bucindolol 59 urocortin 2 59 placebo controlled clinical 59 APTIVUS 59 calcineurin inhibitors 59 SUTENT ® 59 partial agonist 59 NasalFent 59 otelixizumab 59 CG# [003] 59 TTF Therapy 59 dexamethasone Decadron 59 Seliciclib 59 multitargeted 59 CIMZIA ™ 59 cangrelor 59 Enzastaurin 59 pexiganan 59 DPP4 inhibitor 59 belinostat 59 nucleoside analogue 59 Androxal ® 59 superficial bladder cancer 59 HGS ETR1 59 Cloretazine 59 humanized anti 59 endothelin receptor antagonists 59 VitiGam 59 CAPHOSOL 59 anti angiogenic agent 59 GAP #B# 59 Zolinza 59 CYT# 59 LNPs 59 herpetic keratitis 59 SinuNase ™ 59 paclitaxel Taxol ® 59 REMUNE R 59 somatostatin analogue 59 androgen receptor antagonist 59 ularitide 59 Thiarabine 59 tumor necrosis 59 Phase Ib clinical 59 KNS # 59 refractory gout 59 compound AEZS 59 Candesartan 59 Tesmilifene 59 CIMZIA TM 59 UVIDEM 59 Vicriviroc 59 ELND-#/AZD-# 59 modulators SERMs 59 afamelanotide 59 Amrubicin 59 Elacytarabine 59 RAV# 59 Phase 2a trial 59 pediatric acute lymphoblastic 59 Loramyc R 59 siRNA therapeutic 59 GEM OS2 59 cilengitide 59 Vandetanib 59 Golimumab 59 non nucleoside HCV 59 sorafenib Nexavar 59 PI3K inhibitor 59 vilazodone 58 Phase IIa trial 58 REMINYL ® 58 immunotherapeutic vaccine 58 bicifadine 58 peripherally acting 58 Lubiprostone 58 visilizumab 58 serotonin norepinephrine reuptake inhibitor 58 tesetaxel 58 Phase 2b study 58 uricase 58 selective inhibition 58 phase IIb 58 Hsp# inhibitor 58 alpha blocker 58 reslizumab 58 kinase inhibition 58 ZOLINZA 58 Urocortin 2 58 APOPTONE 58 chemopreventive agent 58 2 methoxyestradiol 58 Nasulin 58 Menerba 58 INS# [001] 58 Alexza Staccato 58 rNAPc2 58 Fodosine 58 Androxal TM 58 dasatinib Sprycel 58 BENICAR HCT 58 glucagon receptor 58 E2F Decoy 58 Dr. Fahar Merchant 58 Elesclomol 58 anti leukemic 58 protein tyrosine phosphatase 1B 58 antiangiogenic activity 58 ProLindac TM 58 GSK# [002] 58 Amigal 58 Afatinib 58 pharmacokinetics PK 58 HuMax CD4 58 including eniluracil ADH 58 rBChE 58 Ceflatonin R 58 Vernakalant 58 SILENOR 58 selective receptor agonist 58 small molecule tyrosine 58 Relivar 58 LHRH receptor positive 58 TLR9 agonist 58 somatostatin analog 58 Src inhibitors 58 Prodarsan ® 58 GALNS 58 Dapagliflozin 58 COREG CR 58 antitumor efficacy 58 Endeavor DES 58 Fludara ® 58 A3 adenosine receptor 58 Rigel R# 58 Zenvia ™ 58 MKC# MT 58 subcutaneously administered 58 RhuDex ® 58 orally bioavailable mimics 58 alemtuzumab Campath 58 delipidation 58 ocular formulation 58 Anticalin R 58 allergic airway inflammation 58 Serdaxin 58 NEUGENE 58 Phase 2a clinical 58 factor Xa inhibitor 58 COMT inhibitors 58 Alzhemed TM 58 Exherin TM 58 AzaSite Plus 58 Cimzia TM 58 Ozarelix 58 Fidaxomicin 58 Resten NG 58 OncoGel 58 Aurexis 58 zotarolimus 58 anti fibrotic 58 OncoVex 58 human microdosing 58 Sphingomab 58 CANCIDAS 58 PARI Pharma GmbH 58 Firazyr 58 rALLy clinical trial 58 Telatinib 58 Rosuvastatin 58 Desmoteplase 58 BRIM2 58 investigational HCV polymerase 58 investigational monoclonal antibody 58 kidney urologic 58 cardio renal 58 Chemophase 58 nucleotide analogue 58 Pagoclone 58 ATL# [002] 58 posaconazole 58 CTCE 58 Alfacell proprietary ribonuclease 58 axitinib 58 nanomolar potency 58 isoform selective 58 TLR8 agonist 58 Tarceva TM 58 Pathway Inhibitor 58 ZD# [001] 58 CCR2 58 Locked Nucleic Acid LNA 58 prescribed proton pump 58 MoxDuo 58 Bendavia 58 romidepsin 58 cardioprotective effects 58 CXB# 58 iroxanadine 58 RezularTM 58 CD3 monoclonal antibody 58 Tolvaptan 58 candidate CRLX# 58 myelofibrosis polycythemia vera 58 AeroLEF TM 58 Zemplar Capsules 58 sunitinib malate 58 TAXUS VI 58 antisense drug 58 oral JAK1 58 dosage regimens 58 Valsartan 58 ALN PCS 58 arterial thrombosis 58 Phenoptin 58 Annamycin 58 Phase IIB 58 rosuvastatin Crestor 58 OXIGON TM 58 selective inhibitor 58 XOPENEX HFA 58 6R BH4 58 Hsp# Inhibitor 58 bendamustine 58 candidate deforolimus 58 ACTEMRA TM 58 dalbavancin 58 NOX E# 58 RNAi therapeutic targeting PCSK9 58 Enkephalin 58 Nanobodies 58 Eculizumab 58 Phase IIb trials 58 pharmacodynamic PD 58 REP# 58 IAP inhibitor 58 EZN 58 Exelixis compounds 58 oral proteasome inhibitor 58 stable nucleic acid 58 VivaGel TM 58 OMP #R# 58 relapsed multiple myeloma 58 clinical pharmacology studies 58 Velcade bortezomib 58 PEGPH# 58 BZL# 58 beta2 agonist 58 sodium thiosulfate STS 58 Alagebrium 58 HuCAL antibodies 58 Troxatyl 58 MB# [004] 58 Durezol 58 volociximab 58 stent DES 58 novel histone deacetylase 58 lumiliximab 58 Acute Ischemic Stroke 58 AAG geldanamycin analog 58 taxane derivative 58 UPLYSO 58 ImmunoVEX HSV2 58 oral rivaroxaban 58 #mg dose [001] 58 bosutinib 58 selective orally bioavailable 58 epothilones 58 Bevirimat 58 generation antisense 58 tolevamer 58 sargramostim 57 CoFactor 57 HSP# inhibitor 57 Voreloxin 57 NS#/#A protease 57 LEVAQUIN ® 57 polymerase inhibitors 57 midstage clinical 57 Glypromate 57 MGCD# [001] 57 initiated Phase Ib 57 PEGylated Fab fragment 57 TREDAPTIVE 57 DiLA2 57 Q#IR 57 ZACTIMA 57 Aptivus ® 57 preclinical compounds 57 EVIZON TM 57 recurrent herpes labialis 57 Temsirolimus 57 vascular disrupting 57 oral anticancer 57 Spiegelmer 57 pioglitazone HCl 57 LymphoStat B belimumab 57 Phase 2b trial 57 DURECT proprietary 57 velafermin 57 Thorough QT 57 HuMax CD# 57 IAP inhibitors 57 CRMD# 57 Phase 2b clinical 57 Rasagiline 57 CINQUIL 57 MIRAPEX ER 57 infliximab Remicade 57 ELND# 57 TAKSTA 57 Iluvien ® 57 levodopa carbidopa 57 insulin sensitizers 57 torezolid phosphate 57 insulin sensitizing 57 Panzem 57 oral taxane 57 tubulin inhibitor 57 HIV integrase inhibitors 57 ABSORB trial 57 GnRH antagonist 57 anti angiogenic agents 57 Targretin capsules 57 GSK '# 57 AKT inhibitor 57 antidiabetic drugs 57 trastuzumab DM1 T DM1 57 peptide conjugated 57 PI3K/mTOR 57 Talabostat 57 mTOR inhibition 57 BRAF inhibitor 57 nanoviricide drug 57 PROCHYMAL 57 Ostabolin C TM 57 TKB# 57 Allovectin 7 ® 57 Darapladib 57 hypoxia activated prodrug 57 TNF Tumor Necrosis Factor 57 bortezomib Velcade 57 small molecule activators 57 Phase III Clinical Trials 57 immatics 57 vivo potency 57 alfuzosin 57 Kahalalide F 57 antiarrhythmic 57 Crofelemer 57 SinuNase TM 57 docetaxel Taxotere ® 57 virus HCV protease inhibitor 57 Curaxin 57 Ramoplanin 57 epigenetic therapies 57 HuMax 57 imatinib Gleevec ® 57 bucindolol 57 BXT # 57 Angiocept 57 adalimumab Humira 57 XP# XP# 57 aflibercept VEGF Trap 57 YONDELIS 57 viral kinetics 57 Icatibant 57 biologic DMARD 57 AVN# [001] 57 highly selective adenosine 57 molecular imaging radiopharmaceutical 57 Cipralex ® 57 dosed orally 57 goserelin 57 lintuzumab SGN 57 Polymer Microspheres 57 radiotherapeutic 57 galiximab 57 nitric oxide donating 57 SGLT2 inhibitors 57 novel topoisomerase 57 tyrosine kinase inhibitor 57 synthetic retinoid 57 MetMAb 57 huC# DM4 57 edifoligide 57 Genasense ® oblimersen 57 JZP 57 ChronVac C R 57 Serdaxin ® 57 Elvitegravir 57 SPC# [001] 57 oral ghrelin agonist 57 platinum chemotherapeutic 57 mg/m2 cohort 57 adipiplon 57 Anidulafungin 57 PI3K inhibitors 57 Investigational eFlow Nebulizer System 57 therapeutic monoclonal antibodies 57 aripiprazole Abilify 57 EGFR inhibitors 57 ARIKACE 57 effector function 57 CDP# 57 Allovectin 7 R 57 Cloretazine VNP#M 57 ABILIFY ® 57 Vascugel ® 57 tasocitinib 57 Synavive ™ 57 DP b# 57 tramiprosate Alzhemed TM 57 PDE4 inhibitors 57 Pitavastatin 57 elvucitabine 57 #ME# 57 Sitagliptin 57 Phase 1b 57 mecamylamine 57 pradefovir 57 Thiovir 57 registrational trial 57 phase 2a 57 SGLT2 57 BiTE 57 non nucleoside 57 Phase 2a 57 TOPIGEN 57 Lu AA# 57 bexarotene 57 ON #.Na 57 Imprime PGG 57 Cethrin R 57 oral FTY# 57 Syncria 57 Pafuramidine 57 etanercept Enbrel 57 HCV polymerase inhibitors 57 trastuzumab emtansine T DM1 57 FGFR 57 vapreotide acetate 57 EVIZON ™ 57 stated Michelle Berrey 57 ANAVEX #-# [001] 57 polymerase inhibitor 57 PrevOnco ™ 57 histone deacetylase inhibitor 57 retinal vein occlusion induced 57 VEGF receptor inhibitor 57 durable remissions 57 integrin inhibitor 57 confirmatory clinical 57 direct renin inhibitor 57 Lisofylline LSF 57 paricalcitol 57 Ridaforolimus 57 PEGylated 57 PANVAC VF 57 EGS# 57 BEMA TM Fentanyl 57 xanthine oxidase inhibitor 57 IgG1 antibody 57 phase III isavuconazole 57 neratinib 57 MT#/MEDI-# 57 DiaPep# 57 pharmacological chaperone 57 mTOR inhibitor 57 MT# MEDI 57 Onalta 57 Alfimeprase 57 gemcitabine cisplatin 57 Onco TCS 57 KSP inhibitor 57 double blinded placebo 57 Aurora kinase inhibitor 57 Flutiform TM 57 GLPG# 57 ALN VSP 57 GW# [003] 57 CobaCyte 57 ALK inhibitor 57 IND submission 57 vicriviroc 57 tipranavir r 57 Alequel ™ 57 pharmacokinetic PK profile 57 regorafenib 57 SPL# Gel vaginal microbicide 57 Fulvestrant 57 dexanabinol 57 Darinaparsin 57 Vaprisol 57 thromboxane A2 57 aerosolized KL4 surfactant 57 Maribavir 57 Iloperidone 57 Carvedilol 57 RSD# 57 opioid induced bowel dysfunction 57 HGS ETR2 57 IL# PE#QQR 57 GED aPC 57 TRIOLEX 57 Procoralan 57 RhuDex 57 FOLFOX6 chemotherapy regimen 56 ghrelin antagonist 56 NO# [002] 56 severe hypersensitivity reactions 56 Albuferon TM 56 gonadotropin releasing hormone GnRH 56 cetuximab Erbitux ® 56 vinca alkaloid 56 lesinurad 56 angiotensin analog 56 EOquin TM 56 Aplidin R 56 canakinumab 56 interferon beta therapy 56 generation URAT1 inhibitor 56 lapatinib Tykerb 56 generation antisense inhibitor 56 Laquinimod 56 XL# XL# XL# 56 Cetrorelix 56 TOCOSOL 56 Nexavar sorafenib 56 DEB#